Skip to content
Disclosery

EXANE DERIVATIVES: CELH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CELH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4 CELH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4 shares
    Change vs previous 13F -2,816 shares

    <0.01% of the 13F portfolio, value $261.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,820 shares
    Change vs previous 13F -723 shares

    0.04% of the 13F portfolio, value $155,598.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,543 shares
    Change vs previous 13F -1,065 shares

    0.06% of the 13F portfolio, value $264,192.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,608 shares
    Change vs previous 13F -760 shares

    0.1% of the 13F portfolio, value $415,120.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 5,368 shares
    Change vs previous 13F -1,718 shares

    0.09% of the 13F portfolio, value $385,199.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 7,086 shares
    Change vs previous 13F -2,808 shares

    0.1% of the 13F portfolio, value $340,467.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 9,894 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $497,744.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).